Clinical trials recruiting for Locally Advanced Rectal Carcinoma
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Capecitabine | 2 |
| Oxaliplatin | 2 |
| Celecoxib | 1 |
| Contact x-ray brachytherapy | 1 |
| Fluorouracil | 1 |
| Intensity-Modulated Radiation Therapy | 1 |
| Leucovorin | 1 |
| Serplulimab | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 1 |
Top cities
Self-screener
Recruiting trials
- Modulated Electro-Hyperthermia in Combination With Multimodal Therapy for Locally Advanced Rectal Cancer
- Organ Preservation in Rectal Cancer: Contact X-ray Brachytherapy vs Extending the Waiting Interval and Local Excision
- Serplulimab Combined With CAPEOX + Celecoxib as Neoadjuvant Treatment for Locally Advanced Rectal Cancer
- Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer
Related conditions
Trials recruiting for Locally Advanced Rectal Carcinoma often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Locally Advanced Rectal Carcinoma trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.